Key result
Among 50,084 patients, CRT-D was associated with higher relative survival and lower observed mortality compared to CRT-P after adjusting for age, sex, and comorbidities.
Why the study?
Does CRT-D improve survival compared to CRT-P in patients requiring cardiac resynchronization therapy?
Does CRT-D improve survival compared to CRT-P in patients requiring cardiac resynchronization therapy?
No takes yet. Share an insight, caveat, or question.
This editorial highlights real-world data showing CRT-D is associated with better relative survival than CRT-P, while emphasizing the critical need to match device longevity with patient life expectancy and comorbidities.
Boriani et al. (2018) conducted an editorial in Heart failure (n=50,084). CRT-D vs. CRT-P was evaluated on Total mortality and relative survival. Among 50,084 patients, CRT-D was associated with higher relative survival and lower observed mortality compared to CRT-P after adjusting for age, sex, and comorbidities.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: